Aditya Birla Sun Life Us Equity Passive FOF

An open ended fund of fund investing in units of overseas ETF’s and/or Index Fundbased on NASDAQ-100 Index

April 2026

Passive Fund of Fund Scheme
Investment Objective
The investment objective of the scheme is to provide long-term capital appreciation by investing in units of overseas ETFs and/ or Index Fund based on NASDAQ-100 Index. The Scheme does not guarantee/indicate any returns. There is no assurance that the objective of the Scheme will be achieved.
Fund Category: Fund of Funds
Fund Snapshot
Fund Manager - Mr. Dhaval Joshi
Managing the Fund Since: November 21, 2022
Experience in Managing the Fund: 3.4 Years
Date of Allotment : Nov 01, 2021
Benchmark: Nasdaq 100 TRI
NAV Regular : 20.90
NAV Direct : 21.26
Load Structure (as % of NAV) (Incl. for SIP)
Entry Load: NIL
Exit Load: NIL
AUM as on April 30, 2026 (in ₹Crore)
Monthly Average AUM 461.01
AUM as on last day 494.07
Base Expense Ratio (BER)
Regular 0.58%
Direct 0.27%
BER excludes brokerage incurred towards execution of trades, transaction cost & statutory levies as applicable to investors. In addition to the above, the scheme will also incur 0.30% i.e total weighted average of the expense ratio levied by the underlying schemes.
Sectoral Contribution(in %)
Portfolio Holdings
Portfolio Holdings as on April 30, 2026
Sector/Issuer Name
% to Net Assets
Mutual Funds Units  
INVESTMENT FUNDS/MUTUAL FUNDS 99.53%
iShares Nasdaq 100 UCITS ETF 99.53%
Net Cash and Cash Equivalent 0.47%
Grand Total 100.00%
Miscellaneous includes securities with exposure of less than 0.01%
Product Label
Aditya Birla Sun Life Us Equity Passive FOF
An open ended fund of fund investing in units of overseas ETF’s and/or Index Fundbased on NASDAQ-100 Index
This product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Return that corresponds generally to the performance of the NASDAQ-100 Index, subject to tracking error
Risk-o-meter
Benchmark Risk-o-meter
Nasdaq 100 TRI

*Investors should consult their financial advisors if in doubt whether the product is suitable for them.